A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors
Patent No. EP2640413 (titled "A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors") was filed by Octapharma on Nov 16, 2011. The application was issued on Jun 12, 2019.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents
EP2640413
- Application Number
- EP11784653A
- Filing Date
- Nov 16, 2011
- Status
- Opposition Rejected
- Apr 28, 2023
- Publication Date
- Jun 12, 2019
- External Links
- Slate, Register , Google Patents